Skip to main content

Advertisement

Fig. 1 | Cancer Cell International

Fig. 1

From: Long noncoding RNA DLX6-AS1 promotes neuroblastoma progression by regulating miR-107/BDNF pathway

Fig. 1

DLX6-AS1 expression is upregulated in NB tissues and cell lines. a Venn diagram (left panel) and Log-rank test (right panel) indicated the identification of differentially expressed lncRNAs (fold change > 1.3, p < 0.05) in 88 NB cases (GSE16476) with various status of death, progression, and INSS stages, and their association with outcome of patients. Kaplan–Meier curves showed overall survival with high or low DLX6-AS1 expression in b public data of 88 (GSE16476) patients and in c our collected data of 36 NB patients. d The qRT-PCR assay indicated the DLX6-AS1 expression (normalized to GAPDH) in NB tissues (n = 36) compared with normal dorsal ganglia (DG, pooling n = 18). e The qRT-PCR assay showed the DLX6-AS1 expression (normalized to GAPDH) in normal dorsal ganglia (DG, pooling n = 18) and NB cell lines. ***p < 0.001

Back to article page